Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
The firm lowered its price target on the shares to $22 from $30. According to the analyst, the downgrade stemmed from a lack of significant positive catalysts for the stock. The note also mentioned that the company's recent product launches were proving to be less impactful than previously expected. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Amphastar Pharmaceuticals? Access our full analysis report here, it's free What Is The Market Telling Us Amphastar Pharmaceuticals's shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 4 days ago when the stock gained 4.4% on the news that the reopening of the Strait of Hormuz signaled a cooling of global logist
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $22.00 price target on the stock.MarketBeat
- Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals (AMPH) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Amphastar Pharmaceuticals (AMPH) had its price target lowered by Barclays PLC from $30.00 to $23.00. They now have an "equal weight" rating on the stock.MarketBeat
AMPH
Earnings
- 2/26/26 - Miss
AMPH
Sec Filings
- 4/13/26 - Form ARS
- 4/13/26 - Form DEFA14A
- 4/13/26 - Form DEF
- AMPH's page on the SEC website